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Mechanisms underlying cell death in ischemia-like
damage to the rat spinal cord in vitro
E Bianchetti1, M Mladinic1,2,3 and A Nistri*,1,2
New spinal cord injury (SCI) cases are frequently due to non-traumatic causes, including vascular disorders. To develop
mechanism-based neuroprotective strategies for acute SCI requires full understanding of the early pathophysiological changes
to prevent disability and paralysis. The aim of our study was to identify the molecular and cellular mechanisms of cell death
triggered by a pathological medium (PM) mimicking ischemia in the rat spinal cord in vitro. We previously showed that
extracellular Mg2þ (1 mM) worsened PM-induced damage and inhibited locomotor function. The present study indicated that 1 h
of PMþMg2þ application induced delayed pyknosis chiefly in the spinal white matter via overactivation of poly (ADP-ribose)
polymerase 1 (PARP1), suggesting cell death mediated by the process of parthanatos that was largely suppressed by
pharmacological block of PARP-1. Gray matter damage was less intense and concentrated in dorsal horn neurons and
motoneurons that became immunoreactive for the mitochondrial apoptosis-inducing factor (the intracellular effector of
parthanatos) translocated into the nucleus to induce chromatin condensation and DNA fragmentation. Immunoreactivity to
TRPM ion channels believed to be involved in ischemic brain damage was also investigated. TRPM2 channel expression was
enhanced 24 h later in dorsal horn and motoneurons, whereas TRPM7 channel expression concomitantly decreased. Conversely,
TRPM7 expression was found earlier (3 h) in white matter cells, whereas TRPM2 remained undetectable. Simulating acute
ischemic-like damage in vitro in the presence of Mg2þ showed how, during the first 24 h, this divalent cation unveiled differential
vulnerability of white matter cells and motoneurons, with distinct changes in their TRPM expression.
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The clinical scenario of new spinal cord injury (SCI) cases is
changing because trauma is no more the leading cause.1
Non-traumatic SCI originates from vertebral stenosis, tumors,
or cardiovascular disorders that comprise a cluster of post-
surgical paralysis after abdominal aorta surgery.1 Although
non-traumatic lesions are usually incomplete, the clinical
symptoms are severe, and include paralysis and sensory
dysfunction. A typical feature of SCI is the delayed onset of a
secondary lesion, with cell death affecting the initially spared
neighboring tissue through complex mechanisms. This is an
important issue, as a prerequisite to the development of
mechanism-based neuroprotective strategies for acute SCI is
a detailed understanding of the early pathophysiological
changes. On the assumption that brain lesions are transiently
associated with decreased extracellular Mg2þ concentra-
tion,2 even if this observation has not been systematically
confirmed in humans,3 Mg2þ solution infusion was tested and
was found to worsen the outcome in patients with traumatic
brain lesions.4,5 This result was also observed in stroke
patients.6 In accordance with this view are reports on the lack
of effectiveness of exogenous Mg2þ on experimental SCI or
neonatal brain injury.7,8
To explore the cell death mechanisms, our laboratory has
developed an in vitro neonatal rat spinal cord model to mimic
the metabolic perturbation (hypoxia, aglycemia, oxidative
stress, acidosis, and toxic free radicals with low extracellular
Mg2þ ) occurring in vivo after ischemic SCI.9 This model is
based on the transient application of a toxic medium (termed
‘pathological medium’, PM) that recapitulates the chief
elements of metabolic dysfunction occurring in vivo and
depresses locomotor network function with cell death
predominantly in the white matter via an apoptotic pathway.
We have observed that more extensive pyknosis with block
of locomotor network activity is evoked when PM is
applied with a standard concentration (1mM) of extracellular
Mg2þ 10 when compared with preparations treated with
Mg-free PM.
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Although Mg2þ is essential for numerous enzymatic
reactions,11 novel targets of Mg2þ on the central nervous
system have emerged. In particular, Mg2þ gates the activity
of TRPM7, a bifunctional protein containing a protein kinase
fused to an ion channel12 and having a key role in neuronal
death caused by oxidative stress and excitotoxicity.13 Further,
TRPM2 (amember of the same channel family andmodulated
by Mg2þ ) is involved in the delayed death of brain neurons
after experimental ischemia.13–15 The aim of the present
report was to investigate whether the increased severity of
spinal damage evoked by PMþMg2þ was due to recruitment
of additional cell death pathways, as well as study their identity
and the potential involvement of TRPM2 and TRPM7.
Results
Cell death induced by PMþMg2þ . Our previous report10
indicated that a 1-h application of PM containing 1mM Mg2þ
induces, 24 h later, significant damage to the in vitro spinal
cord. This observation was confirmed by detecting extensive
pyknosis in the white matter region at 24 h (see arrow in the
example of Figure 1a). Figure 1b indicates the four ROIs
used for these experiments, whereas Figure 1c quantifies
these data. Significant pyknosis already emerged 3 h after
washing out the toxic medium (Figure 1c). It is noteworthy
that sham preparations (kept in standard Krebs for up to 24 h)
or mock preparations (bathed for 1 h in Mg-free Krebs
solution to which 1mM Mg2þ was added to test for any
artifact due to solution application and washout procedure)
showed no significant pyknosis (Figure 1c). Thus, unlike the
outcome with PM without Mg2þ (Figure 1c), the presence of
this divalent cation worsened an ischemia-like metabolic
perturbation, and cell damage developed over 24 h.
Characterization of the white matter damage evoked by
PMþMg2þ . Using biomarkers previously employed to
characterize spinal injury,16,17 we next investigated the
type of cell damage evoked by PMþMg2þ by studying
immunoreactivity to phospho-histone2A.X(Ser139) (H2AX a
marker of DNA double-strand breaks)18 and active-caspase
3 (a marker of apoptosis)19 in the white matter ROI where
extensive pyknosis was found (Figure 1c). Figure 2a shows
that the percentage of H2AX-positive cells in the white matter
region was higher in treated than in sham preparations at 3 or
24 h. Nevertheless, unlike the number of pyknotic nuclei
(Figure 1c), the number of H2AX-positive elements did not
increase from 3 to 24 h (Figure 2a), suggesting the presence
of early DNA double-strand lesions in keeping with former
studies.18,20 By comparing the 24-h data in Figures 1c and
2a, it seems likely that the PMþMg2þ damage affected the
vast majority of white matter elements, as about 75% of them
showed pyknosis and 25% had H2AX immunoreactivity.
Interestingly, in the same ROI, immunopositivity for active
caspase 3 (an important executor of apoptosis), although
limited too5% of the cells, was larger than that in the sham
condition (Figure 2b).
The poor expression of active caspase 3 was an
unexpected result, as PM (without Mg2þ ) is known to damage
the spinal white matter primarily via caspase-dependent
apoptosis.16 When the spinal damage is evoked by
excitotoxicity, the main process of cell death is a
non-apoptotic mechanism termed parthanatos caused
Figure 1 Pyknosis in the rat spinal cord in vitro following transient (1 h) application of pathological medium with or without Mg2þ . (a) Example of the spinal cord pyknosis
(see arrow) in the white matter 3 h after washout of PMþMg2þ . Scale bar: 10mm. (b) Schematic representation of the four spinal ROIs used for analysis. DH, dorsal horn;
CENT, central area; VH, ventral horn; WM, white matter. (c) Histograms show percentage of pyknotic cells in the four ROIs shown in (b). Mock data refer to preparations in
which washout of incubating medium was performed to test for any potential mechanical damage related to this procedure. Note: statistically significant increase in the white
matter pyknotic cell number in the samples treated with PM with or without Mg2þversus sham preparations at 3 or 24 h after washout. Data are the average taken from nine
sections from three rats. The Mann–Whitney test was used after performing an ANOVA Tukey test; *P¼ 0.022; **P¼ 0.004; ***Po0.001
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Figure 2 Characterization of white matter damage evoked by PMþMg2þ . (a) Left, examples of immunostaining for H2AX in the ventral quadrant of the spinal cord in
which the white matter shows minimal signal positivity in sham conditions. Scale bar: 30 mm; right, percentage of H2AX-positive cells in the ventrolateral white matter after
PMþMg2þ ; n¼ 9 sections, ***Po0.001. (b) Left, examples of immunostaining for active caspase 3 in the same ROIs as shown in (a); right, percentage of caspase 3-
positive cells in the ventrolateral white matter after PMþMg2þ ; n¼ 9 sections, *P¼ 0.034; ***Po0.001. (c) Histograms showing pyknotic nuclei after addition (on
PMþMg2þ washout) of caspase 3 inhibitor (1 mM), PJ34 (60 mM), or both. n¼ 9; ***Po0.001. For data shown in (a), (b) and (c), the Mann–Whitney test was used after
performing an ANOVA Tukey test. (d) Histograms show PAR tissue levels in various experimental conditions. For each test, data are from three spinal cords tested in
duplicate; one-way Anova Tukey test; ***Po0.001
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by excessive activation of PARP-1 (poly (ADP-ribose)
polymerase 1) to synthesize toxic concentrations of PAR
(poly-ADP-ribose) that disrupt cell energy stores.21 Therefore,
in the present report we investigated whether, in the white
matter ROI, PMþMg2þ could stimulate excessive production
of PAR, which is known to induce pyknosis.21,22 Thus, we
tested whether application of a selective inhibitor of either
PARP-1 activity or caspase-3 might protect white matter
elements from PMþMg2þ toxicity. To this end, we used
PJ34 (N-(5,6-dihydro-6-oxo-2-phenanthridinyl)-2-acetamide)
to block PARP-123 and the caspase peptide inhibitor (caspase
3 inhibitor II, Z-DEVD-fmk) to block apoptosis,24 which were
applied (for 24 h) either alone or in combination immediately
after washing out PMþMg2þ . Figure 2c summarizes these
data: whereas the caspase inhibitor alone did not significantly
reduce pyknosis (5% change; see Figure 2c), PJ34
significantly (Po0.001) decreased pyknosis by 425%, an
effect even stronger (435%) when the two pharmacological
blockers were applied together (Po0.001), indicating partial
convergence of these two cell death processes. Neither
inhibitor had any effect on sham preparations (Figure 2c).
Figure 2d indicates that PJ34 applied at a concentration of
60 mM was a strong inhibitor of the tissue generation of PAR
measured with an enzyme-linked immunosorbent assay
(ELISA). Halving the concentration of PJ was less effective.
Figure 3a illustrates an example of co-staining with
4,6-diamidino-2-phenylindole (DAPI) and the PAR antibody of
a pyknotic white matter cell 24 h after PMþMg2þ application.
Figure 3b shows that, among the total DAPI-stained elements,
the percentage of PAR-positive cells in white matter ROI
(hatched bars) had already increased significantly (Po0.001)
3h after PMþMg2þ , and it remained elevated (Po0.001) 24h
later. Figure 3b (filled bars) also quantifies co-occurrence of
PAR immunopositivity together with pyknosis for the total
number of pyknotic cells; it is clear that PMþMg2þ induced a
significant (Po0.001) increase in the association between
PAR and pyknosis at 3 and 24h. In fact, few cells were PAR
positive without pyknotic nucleus at either time (open bars).
This finding suggested that PMþMg2þ had transformed the
white matter damage from the apoptosis previously detected
with PM alone10 to a process with parthanatos characteristics.
We thus wondered whether an analogous process might have
developed in the gray matter.
Characterization of gray matter damage evoked by PMþ
Mg2þ . Despite the comparatively modest extent of the
lesion to the gray matter induced by PMþMg2þ (see
Figure 1c), this protocol is known to inhibit locomotor
network function.10 To further analyze neuronal damage, the
present study quantified the percentage of NeuN-positive
neurons in dorsal, central, and ventral ROIs at 3 and 24 h
after PMþMg2þ . Figure 4 demonstrates that significant
neuronal loss was absent at 3 h, and became apparent at
24 h as far as the dorsal and ventral ROIs were concerned.
Thus, in accordance with pyknosis data (Figure 1c), PMþ
Mg2þ had an early effect on white matter elements, and a
later one on gray matter cells, which, in the ventral horn,
constitute a small minority of the spinal cell population.25
As, among gray matter regions, the late damage by PMþ
Mg2þ appeared to mostly affect the ventral ROI that contains
motoneurons, namely, the essential output elements of
the locomotor network, we next investigated dysfunctional
changes in motoneurons, identified as large (425 mmsomatic
diameter) cells located in the ventral horn and immunopositive
for choline acetyltransferase (ChAT, the cytoplasmic ACh
synthetic enzyme), and for SMI32, a marker for motoneuron
cytoskeleton.26,27 Figure 5a shows that the number of ChAT-
positive motoneurons did not change following PMþMg2þ at
3 or 24 h, whereas the average intensity of the SMI32 signal
was significantly (Po0.001) decreased at 3 and 24 h
(Figure 5b). This observation suggests that, despite the
Figure 3 PAR immunoreactivity in the white matter after PMþMg2þ .
(a) Example of co-staining with DAPI (left) and PAR immunoreactivity (middle) of
a pyknotic white matter cell 24 h after PMþMg2þ application; right panel shows
overlapped images; scale bar: 10 mm. (b) Histograms show percentage of
PAR-positive cells (hatched bars) over total DAPI-stained elements, co-occurrence
of PAR immunopositivity and pyknosis (filled bars) and total number of pyknotic cells
(open bars). n¼ 9; the Mann–Whitney test was used after performing an ANOVA
Tukey test; ***Po0.001
Figure 4 Characterization of neuronal damage evoked by PMþMg2þ .
Histograms show percentage of neurons (NeuN-positive cells) observed in three
ROIs in control or after PMþMg2þ washout (3 or 24 h). The Mann–Whitney test
was used after performing an ANOVA Tukey test, n¼ 9; **P¼ 0.003; ***Po0.001
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unaltered number of motoneurons, these cells showed signs
of cytoskeleton damage.
Neuronal distress can strongly activate PARP-1 to generate
toxic levels of PAR (‘parthanatos’).28,29 In accordance with this
notion, a significant increase in PAR immunoreactivity was
detected in motoneurons early after PMþMg2þ , as exempli-
fied in Figure 5c and quantified in Figure 5d. It is noteworthy that
the PAR signal intensity did not increase further at 24h.
The toxic action of PAR is typically executed via transloca-
tion of the transcription factor apoptosis-inducing factor (AIF)
from the mitochondria to the nucleus22,29,30 and it thus
represents a delayed cell death signal. We examined the
expression and translocation of AIF in motoneurons as
indicated in Figures 6a and b. In sham conditions, the
confocal line scan of the motoneuron cell body (see line
across cell soma in Figure 6a, left) demonstrated that its DAPI
staining was confined to the cell nucleus (blue line; Figure 6a,
right), whereas AIF (red line in Figure 6a, right) was poorly
expressed throughout the cell. In contrast, 24 h after PMþ
Mg2þ (Figure 6b), whereas DAPI staining was still restricted
to the nucleus, AIF immunoreactivity was diffused and
extended to the cell nucleus as well. Detection of AIF in the
motoneuron nucleus was accompanied by loss of expression
of the nuclear transcription factor NeuN as shown in Figure 6c
(see open arrow). Finally, Figure 6d indicates that, 24 h after
PMþMg2þ , about 30% of motoneurons showed AIF nuclear
translocation. All together, these observations suggest
that, despite the persistence of ChAT immunoreactivity, a
significant fraction of motoneurons displayed multiple signs
of distress 24 h after PMþMg2þ , consistent with the onset of
a parthanatos-like process.
Expression of TRPM7 or TRPM2 after PMþMg2þ
application. TRPM7 and TRPM2 are members of a large
family of ion channels31 believed to play an important role in
the neurodegeneration evoked by ischemia in vivo or by
ischemia-like conditions in vitro.13,14,32–35 In the present
study, we found undetectable TRPM7 immunopositivity in the
white matter from freshly frozen preparations (Figure 7a,
open circle), or under 3 and 24 h sham conditions (Figure 7a,
Figure 5 Characterization of motoneuron damage evoked by PMþMg2þ . (a) Histograms show motoneuron numbers counted with ChAT immunostaining. Inset shows
an example of ChAT-stained ventral horn cells in sham-24 or PMþMg-24 conditions. Bar¼ 30mm. (b) Histograms show motoneuron SMI32 signal intensity that was already
decreased 3 h after PMþMg2þ washout; a t-test was performed after an ANOVA Tukey test; ***Po0.001. Inset shows an example of SMI32-stained ventral horn cells in
sham-24 h or PMþMg-24 h conditions. Bar¼ 30mm. (c) Examples of PAR immunoreactivity detected in motoneurons 3 h after PMþMg2þ ; scale bar: 30mm.
(d) Histograms show motoneuron PAR signal intensity enhanced after PMþMg2þ ; a Mann–Whitney test was performed after an ANOVA Tukey test, ***Po0.001. For all
experiments, data are from nine spinal sections from three rats
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open squares), or immediately after washing out PMþMg2þ
(Figure 7a, filled triangle). Vice versa, a strong signal became
apparent 3 h after PMþMg2þ washout and remained
stable 24 h later (Figure 7a, filled triangles). White matter
TRPM7 immunoreactivity was most frequently detected in
pyknotic cells (see arrows in Figure 7b) as quantified in
Figure 7c (filled bars). In the white matter ROI, there was no
significant TRPM2 immunoreactivity under treated or sham
conditions (not shown). Thus, it appeared that about half of
the white matter elements that died (pyknosis) after PMþ
Mg2þ treatment also expressed strong positivity to TRPM7.
In contrast to these data from the white matter ROI, in the
three gray matter ROIs we found baseline positivity to TRPM7
(Figures 8a and b) and TRPM2 (Figure 8c). After washing out
PMþMg2þ , the TRPM7signal was found significantly lower
24 h later (Figures 8a and b) in the dorsal horn ROI (Po0.001)
and in the motoneuron ROI (P¼ 0.002). Conversely, for the
same ROIs, TRPM2 immunopositivity appeared to move in
the opposite direction with a delayed increase 24 h after
washing out PMþMg2þ (Figure 8c).
Discussion
The focus of the present study was the role of extracellular
Mg2þ in the genesis of cell death after transient application of
a solution mimicking ischemia conditions. The present data
Figure 6 AIF signal in motoneurons after PMþMg2þ . (a) An example of AIF cytoplasmic distribution in sham motoneurons (left), with confocal line scan analysis plotted
on the right for the cell indicated by an open bar on the left. Note strong nuclear distribution of DAPI (blue) versus AIF. (b) Analogous presentation of data referred to sample
24 h after PMþMg2þ . Note DAPI signal colocalized with AIF in the nucleus. (c) Examples of DAPI (blue) co-staining with AIF (red; left columns) or NeuN (green; right
columns) under sham conditions (top row) or after PMþMg2þ (bottom row). Under sham conditions, the AIF signal was cytoplasmic and the NeuN signal was nuclear. After
PMþMg2þ , the AIF signal is expressed by the motoneuron nucleus that has lost NeuN immunoreactivity. Scale bar: 30mm. (d) Histograms show percentage of motoneurons
expressing nuclear AIF after PMþMg2þ . For all experiments, data are from nine spinal sections from three rats (see white arrow)
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indicate that the presence of this divalent cation contributed to
enhancing and widening the delayed damage to the white and
gray matters of the rat spinal cord by facilitating a distinct cell
death pathway.
A model of non-traumatic injury. The growing number of
non-traumatic causes of SCI1 led us to examine the
processes responsible for early cell death after the in vitro
insult. Our previous investigations indicated that applying a
toxic solution containing free oxygen radicals with no oxygen
or glucose supply especially damaged the white matter
elements, with moderate impairment of locomotor-like
patterns that were still present at regular frequency but with
clearly lower amplitude.9,10 Nevertheless, when the same
toxic solution contained the standard extracellular Mg2þ
concentration, the histological damage was intensified and
locomotor patterns were inhibited.10 The present report
sought to characterize the processes responsible for this
damage enhancement.
PMþMg2þ evoked lesion of white matter elements. This
solution was confirmed to produce stronger damage than the
original PM (without added Mg2þ ), as pyknosis was seen in
about 80% of the ROI white matter elements and was
accompanied by early phosphohistone positivity to indicate
relatively rapid DNA damage.18 The canonical marker of
apoptosis, namely, activated caspase 3,19 was evident in a
small minority of white matter cells only. Perhaps the damage
had evolved so quickly that cell death had become
apparent before any extensive apoptosis could be produced.
In keeping with this view was our observation that a
pharmacological inhibitor of apoptosis24 did not arrest
pyknosis, although it reduced pyknosis when coapplied with
PJ34, the inhibitor of PARP-1,23 which is essential for DNA
damage repair and whose hyperactivation generates the
toxic product PAR.23,28,29 PAR was already strongly
increased 3 h after the end of PMþMg2þ application,
suggesting a narrow time window before irreversible cell
damage could occur (demonstrated by colocalization of PAR
and pyknosis). When PJ34 is administered early during the
lesion protocol, a degree of functional neuroprotection is
observed36 in accordance with the present data. In general,
the present results suggest that the presence of Mg2þ during
the ischemic-like protocol aggravated the damage to the
white matter cells by promoting the activation of at least one
major cell death pathway, namely, parthanatos.
Gray matter damage by PMþMg2þ . Alongside low-scale
pyknosis, most NeuN-positive neurons exhibited a gradient
of neuronal loss: the strongest in the ventral horn, a modest
one in the dorsal horn, and apparently none in the central
region. Motoneurons, however, did not disappear, as their
typical marker ChAT was preserved even 24 h later. These
cells were, nevertheless, showing signs of distress because
their SMI32 positivity was decreased, suggesting distur-
bance of their cytoskeleton. Conversely, a traumatic lesion
in vivo is associated, a few days later, with loss of ChAT,
followed by upregulation of SMI32 expression by surviving
motoneurons, taken as an index of cell repair.37 The
differential evolution of ChAT and SMI32 in the present
study compared with in vivo experiments is unlikely due to
motoneuronal maturation, as neonatal motoneurons already
show adult somatic size.38 Accordingly, in the in vitro rat
spinal cord model, the number of SMI32- and ChAT-positive
cells and their staining pattern remain constant in the first
week of life.25 Further, AIF-dependent cell death mediates
neuronal death after hypoxia–ischemia in the neonatal rat
brain39 as much as in the adult brain.22 Hence, dynamic
changes in these two biomarkers may indicate distinct
processes and time course underlying either degenerative
mechanisms or restoration.
Concomitant with the fall in SMI32 signal was the detection
of rising PAR immunoreactivity in the same cells. This was
likely a sign of impending death, as it was accompanied by
strong AIF translocation into the nucleus, a known effector of
cell death.29 Interestingly, AIF nuclear translocation was
closely associated with loss of NeuN positivity. NeuN is an
intrinsic component of the neuronal nuclear matrix,40 whose
fast degradation (already at 1 h after injury)41 precedes
cytoskeletal changes (identified, for instance, with SMI32
positivity) in injured motoneurons.37
These results imply that various motoneuron biomarkers
should be tested for assessing damage in pathological
conditions, as their significance in the diagnosis of cell death
is time-dependent. Thus, we surmise that the development of
Figure 7 White matter expression of TRPM7 after PMþMg2þ application.
(a) Plot of the number of TRPM7-positive white matter cells against time following
PMþMg2þ (filled triangles). TRPM7 immunopositivity was undetectable in the
white matter from freshly frozen preparations (open circle at time 0) or under sham
conditions (open squares at 3 and 24 h). (b) Examples of TRPM7-positive white
matter cells (see arrows) after PMþMg2þ . (c) Histograms show percentage of
TRPM7-positive/pyknotic white matter cells calculated with respect to the total
number of pyknotic elements (filled bars). Open bars show percentage of TRPM7-
positive cells without pyknosis over total number of non-pyknotic cells. We also
quantified co-occurrence of TRPM7 immunopositivity together with pyknosis for the
total number of pyknotic cells. All data are from nine spinal sections from three rats
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parthanatos in motoneurons occurred on a slower time base
than in the white matter. Nevertheless, these pathological
changes have a strong negative impact on locomotor network
function.10
TRPM2 and TRPM7 roles in the PMþMg2þ effects.
These two membrane channels have recently been investi-
gated for their contribution to ischemic cell death in the
brain.13,35 These channels are gated open by intracellular
PAR, reactive oxygen species and Mg2þ (as under normal
conditions such channels are minimally activated).13,14,42–44
For these reasons, we studied how these channels were
expressed during our experimental protocol. In view of
reports on the ubiquitous occurrence of TRPM7 expres-
sion,45 their immunohistochemical absence in the white
matter under sham conditions was not anticipated. This
phenomenon could not be attributed to loss of protein
expression by keeping the preparation in vitro because
analogous lack of signal was found when the tissue was
frozen immediately after dissection. It seems feasible that
immaturity of the neonatal spinal cord was a factor for poor
TRPM7 expression in controls. It was, however, clear that
already 3 h after PMþMg2þ exposure a large number of
white matter cells (with pyknotic nucleus) were positive to
Figure 8 Gray matter expression of TRPM7 or TRPM2 after PMþMg2þ application. (a) Examples of TRPM7 immunoreactivity in the ventral horn under sham conditions
or 24 h after PMþMg2þ . (b) Histograms show distribution of TRPM7 immunoreactivity in dorsal, central and motoneuron ROIs. Note the significant fall in average signal
intensity 24 h after PMþMg2þ for dorsal and motoneuron ROIs; **P¼ 0.002; ***Po0.001. (c) Examples of TRPM2 immunoreactivity in ventral horn under sham conditions
or 24 h after PMþMg2þ . (d) Histograms show distribution of TRPM2 immunoreactivity in dorsal, central and motoneuron ROIs. Note the significant increase in TRPM2 signal
in all three ROIs examined; one-way Anova Tukey test, **P¼ 0.004; ***Po0.001. All data are from nine spinal sections from three rats
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TRPM7. Our interpretation is that metabolic distress in the
presence of Mg2þ triggered rapid trafficking of TRPM7
proteins to the cell membrane, where their activation might
have contributed to the observed damage.
Unlike the white matter cells, in the gray matter, baseline
expression of TRPM7 fell in motoneurons and dorsal neurons
24h after PMþMg2þ when low-scale pyknosis was
manifested. TRPM2 expression (that could not be observed
in the whitematter) showed an opposite pattern with a late rise
in gray matter neurons, which was especially strong in the
central region. It is not feasible to relate the intensity of
immunoreactivity to channel activation; thus, the present
results about differential TRPM7 and TRPM2 signal
intensities cannot be extrapolated to a specific role of these
proteins in neuronal survival or death. Nonetheless, the
present observations indicate a significant dichotomy in
TRPM7 and TRPM2 channel expression, whose molecular
mechanism remains to be clarified. Future studies are
necessary to investigate the functional activity of TRPM2 or
TRPM7 channels under the present experimental protocols.
This goal is, however, complex because of the difficulty to
isolate, in an intact network system, the contribution of these
conductances in the absence of selective inhibitors, the
widespread dysfunction of motoneurons and the lack of
knockout rat models.
Even if both TRPM7 and TRPM2 channels have been
proposed to be mediators of neuronal death after ischemia,46
the time dependence of their differential activation is not
known under the present conditions. As TRPM2 channels are
inhibited by intracellular glutathione,47 TRPM2 overexpression
was perhaps related to metabolic dysfunction that developed
early for the superficial motoneurons. The effects of the toxic
solution on deep central neurons were likely delayed
with morphological preservation of such cells that had shown
the strongest TRPM2 expression. One hypothesis is that
the TRPM2 activation would eventually lead to central neuron
damage occurring at the time point beyond the 24-h in vitro
survival of the isolated control spinal cord, and thus
outside our experimental range. As TRPM2 channels are
characterized by small conductance,14 it would follow that a
small-scale influx of these cations might determine the
delayed trigger of parthanatos.
Role of extracellular Mg2þ . From the point of view of an
in vitro spinal model, it is apparent that the standard
concentration (1mM) of Mg2þ amplified white matter
damage and extended it to the gray matter. The reason
might reside in the differential expression of TRPM7 and
TRPM2, plus the degree of PAR hyperproduction at the early
stage of damage, because the concentrations of PAR and
intracellular Mg2þ are potent modulators of the activity of
these channels.13,46 Recent studies with in vitro brainstem
neurons have proposed that changes in intracellular Mg2þ
concentrations occurring during pathological states can
affect the conductance of neuronal Cx36 gap junctions48
and presumably shape the damage outcome. Although
chemical synaptic inputs and Cx36-dependent electrical
synapses contribute to synchronization of spinal motoneuron
function,49 the expressions of Cx36 and Cx32 mRNA and
proteins are sparse and unchanged after rat SCI.50 The
complexity of the processes underlying ischemia-induced
damage in the spinal cord even when studied with an in vitro
model implies diversity of molecular pathways with distinct
time dependence and cell specificity, factors that contribute
to the difficulty of implementing successful neuroprotection
in vivo.51–53 The present report suggests that the extra-
cellular level of Mg2þ largely affects cell death mechanisms
in the spinal cord and extends damage to motoneurons by
facilitating the onset of parthanatos.
Materials and Methods
Rat spinal cord preparation. The experiments were performed on
neonatal Wistar rats of postnatal age 0–1 days in accordance with the guidelines
of the National Institutes of Health and the Italian act D.Lgs. 27/1/92 no. 116
(implementing the European Community directives no. 86/609 and 93/88), and the
protocols were approved by the SISSA ethical committee for animal experimenta-
tion. We minimized the number of animals used in order to allow clear statistical
analysis. Spinal cords were carefully dissected out from pups under urethane
anesthesia (0.2ml i.p. of a 10% w/v solution) at room temperature, with continuous
superfusion with Kreb’s solution containing (in mM) the following: NaCl, 113; KCl,
4.5; MgCl27H2O, 1; CaCl2, 2; NaH2PO4, 1; NaHCO3, 25; glucose, 11; gassed with
95% O2/5% CO2, pH 7.4 at room temperature (22 1C), as described previously.
26
Protocol for spinal cord lesion. Our aim was to generate an
experimental condition that might mimic the acute clinical setting when the
metabolic insult is often temporary because of intensive care treatment to correct
the metabolic derangement. In accordance with our studies10,11 and to simulate
the biochemical conditions believed to occur at the site of the lesion, we used a
metabolic perturbation protocol consisting of the transient application of PM
(see below) with the addition of 1mM Mg2þ .10 This protocol is known to induce a
pathological condition that includes locomotor network inhibition and histological
damage.10 Thus, a solution containing 10mM H2O2, 500mM sodium nitroprusside
(SNP) and 1mM Mg2þ and lacking oxygen and glucose was applied for 1 h.
NaHCO3 was omitted and 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
(HEPES) was added to reach the pH range of 6.75–6.80 (with 0.1 N NaOH) and
the osmolarity was lowered to 230–240mOsm. This solution recapitulates the
biochemical derangement believed to occur in the spinal cord after acute
non-traumatic injury.9
After a 1-h application of PMþMg2þ , the latter solution was washed out and
standard Kreb’s solution was superfused again for up to 24 h, after which
preparations were fixed as previously reported9 and processed for histology as
detailed below. Sham experiments were performed by keeping the preparations for
analogous times in the same experimental setup without applying a toxic medium.
Quantification of dead cells. Using a Zeiss Axioskop2 microscope
(Oberkochen, Germany) and Metavue software (Metamorph suite sold by
Molecular Devices, Sunnyvale, CA, USA), cell counting was performed after DAPI
staining or NeuN positivity (for neurons). Data were counted with ‘eCELLence’
(Glance Vision Tech., Trieste, Italy) software.9,10 For each histological cross-
section of the spinal cord, four different regions were investigated: dorsal gray
matter (Rexed laminae I–IV), central gray matter (Rexed laminae V–VII and X),
ventral gray matter (Rexed laminae VIII–IX) and ventrolateral white matter. In each
region, three to six fields of 280 280-mm (gray matter) or 100 280-mm (white
matter) area were analyzed. For each experimental group, three spinal cords were
analyzed and, for each spinal cord, 3–4 different sections from T13 to L3 (thoracic
spinal cord segment 13 to lumbar spinal cord segment 3) segments were
examined. Pyknosis was readily observed as a change in nuclear morphology
resulting from chromatin condensation.54
Immunofluorescence procedure. Immunostaining was performed as
previously described.9,26 Briefly, paraformaldehyde-fixed spinal cords were
cryoprotected with 30% sucrose and sectioned (30 mm) with a sliding microtome.
In accordance with our former studies, we analyzed spinal regions between T13
and L3 segments. For all antibodies (except anti-PAR), after incubation in
blocking solution (5% normal goat serum, 5% bovine serum albumin, 0.3%
Triton-X 100) for 1 h at room temperature, the primary antibody was incubated at
4 1C overnight. Before incubating tissue sections with the PAR antibody, an
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antigen-retrieval procedure was performed by treating (20min at 60 1C) samples
with Tromethamine (TRIS)—Ethylenediaminetetraacetic acid (EDTA)—TWEEN 80
(pH¼ 8.5). To preserve the structure of spinal cord slices that could be damaged
by the antigen retrieval procedure, the TRIS–EDTA–TWEEN was washed out with
cold phosphate-buffered solution (PBS) five times to stop the reaction before
mounting the slices for immunostaining. The primary antibodies were visualized
using secondary anti-mouse Alexa fluor 488 or 594 antibodies (1 : 500; see
Supplementary Table 1). Sections were finally stained with DAPI for 20min and
analyzed as detailed below.
All antibodies (except TRPM2 and TRPM7) have been previously used and
validated for immunostaining with our preparations (for ChAT, NeuN, SMI32, see
Taccola et al. 9 and Cifra et al.25; for AIF, cleaved caspase-3, H2AX and PAR, see
Kuzhandaivel et al.16,21). The TRPM2 antibody was validated by Hara et al.55 and
the TRPM7 antibody by Everaerts et al.56
Immunofluorescence data analysis. For each spinal section, images of
the dorsal and ventral horns, the area around the central canal and the
ventrolateral white matter were acquired with a LEICA 6000 microscope ( 40
lens) using identical capture settings throughout, and ensuring that signals were
clearly below saturation and yielding a good signal/noise ratio. For each spinal
region, the acquisition procedure was repeated four times at z axis intervals of
1mm. In order to analyze all these images, we used the 3D Volocity software
(Perkin Elmer, London, UK) applied to four regions of interest (ROIs). For the
dorsal, central and white matter regions, the ROI size was 200 100mm. For
motoneurons, we drew by hand a ventral horn region that comprised
large-diameter (425mm) neurons. For each gray matter ROI, using the ‘voxel
spy’ facility of the software, we calculated the background fluorescence and
included in the analysis only those signals that were higher than this threshold
value. Owing to the large degree of cell meshing in the neuropile, the ROI signal
intensity was evaluated on a gray scale and expressed in arbitrary units (AUs).
The data were averaged from three histological sections from each one of three
rats. In the case of white matter quantification, it was possible to observe individual
cells that were counted and averaged for three sections from each one of
three rats.
This approach was employed for quantifying data concerning immunopositivity to
PAR, ChAT, SMI32, TRPM2 and TRPM7. For caspase 3, phosphohistone and
NeuN data, we used previously published procedures with a Zeiss Axioskop2
microscope and Metavue software.16
Analysis of AIF translocation. Images of single motoneurons were
acquired with a LEICA confocal microscope, using 0.5-mm z sectioning as
reported by Oh et al.57 After reconstructing the cell image, we selected a single
central optical section that comprised the largest nuclear staining with DAPI.
Thereafter, we performed a line scan of such an image to verify the distribution of
AIF immunofluorescence signal in the nucleus and in the cytoplasmic
compartment. The number of reconstructed motoneurons showing AIF nuclear
translocation was quantified with ImageJ (http://rsb.info.nih.gov/ij).
Nuclear and mitochondrial protein extraction. The nuclear extraction
was prepared in accordance with published reports.21,58 Thus, isolated spinal
cords were washed with ice-cold 250-STMDPS buffer (50mM Tris-HCl, pH 7.4,
250mM sucrose, 5mM MgCl2, 1 mM dithiothreitol (DTT), 1 mM phenylmethylsul-
fonyl fluoride (PMSF), 25mg/ml spermine and 25 mg/ml spermidine) and then
submerged in the same. After 15 strokes in a Dounce homogenizer, the extract
was centrifuged at 800 g for 15min. The pellet (Pellet I) was used to prepare the
nuclear fraction. The supernatant was again centrifuged at 6000 g for 15min to
remove mitochondria (Pellet II). To prepare the nuclear fraction, Pellet I was
homogenized with a single stroke in a Dounce homogenizer in 2 M-STMDPS
buffer (50mM Tris-HCl, pH 7.4, 2 M sucrose, 5 mM MgCl2, 1 mM DTT, 1 mM
PMSF, 25mg/ml spermine, and 25mg/ml spermidine) and fractionated at 80 000 g
for 5 min. The resulting pellet was resuspended in nuclear extract buffer (20mM
HEPES, pH 7.9, 1.5 mM MgCl2, 0.5 M NaCl, 0.2 mM EDTA, and 20% glycerol) and
used as the nuclear fraction (Pellet I). Pellet II was resuspended in hypotonic lysis
buffer (10mM HEPES, pH 7.9, 1 mM DTT, plus the protease inhibitor cocktail;
Sigma, Milan, Italy) and incubated on ice for 30min. The suspension was
sonicated to lyse mitochondria. Protein concentrations were determined for the
nuclear fraction and the mitochondrial lysate using the standard bicinchoninic acid
assay following the manufacturer’s protocol (Sigma). For each individual
experiment, three spinal cords were used. The purity of the extracted nuclear
fraction was validated by looking for (with western immunoblotting) any
mitochondrial contamination indicated by the cytochrome C oxidase IV protein
(Abcam, Cambridge, UK) in accordance with the method of Beirowski et al.59
These samples were then used for ELISA.
ELISA quantification of PAR. To obtain evidence for PARP-1 activation
and pharmacological inhibition by N-(5, 6-Dihydro-6-oxo-2-phenanthridinyl)-2-
acetamide (PJ34), we quantified its product PAR in accordance with Nasrabady
et al.60 For this purpose, lysates of spinal cords treated with PMþMg
and/or PJ34, or in sham conditions, were collected 24 h later and their PAR
levels were measured using the PARP in vivo pharmacodynamic assay II
(http//www.trevigen.com/protocols) following the manufacturer’s protocol
(Trevigen, Bologna, Italy). This assay is based on ELISA immunoreactivity resulting
in chemiluminescence signals recorded with a Glomax multi-detection system
(Promega, Milan, Italy). Whenever tests were performed for the action of PJ34,
this substance was added to the cell lysis buffer to avoid inhibitor dilution as per
the manufacturer’s instructions. All samples were run in duplicate. After
background subtraction (blank samples), the net PAR levels were quantified
using a standard linear plot (r¼ 0.98) based on the immunoreactivity induced by
known concentrations (20–1000 pg/ml) of PAR. Data were expressed as pg/ml/
100mg of protein (estimated as indicated below).
Drugs. SNP and PJ34 were purchased from Sigma; H2O2 was obtained from
Carlo Erba Reagents (Milan, Italy); and active caspase 3 inhibitor II was obtained
from CalBiochem-Millipore (Billerica, MA, USA).
Data analysis. The data are shown as mean±S.D. Statistical analysis was
carried out with SigmaStat 3.1 (Systat Software, Chicago, IL, USA). Parametric
and nonparametric data were first distinguished with a normality test (Anova
Tukey) and analyzed with the Student t-test and the Mann–Whitney test,
respectively, in accordance with the software choice. The significance level was
always Po0.05, and n indicates the number of tissue sections.
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